BrightPath Biotherapeutics Co.,Ltd. (4594.T) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenJPY 57.00

From 52W high−40.63%

Volume2.77M

Market capJPY 6.44B

P/E (TTM)—

P/S (TTM)6213.2x

Div yield—

Key dataSep 18, 2026

Open

JPY 57.00

From 52W high

−40.63%

Volume

2.77M

Market cap

JPY 6.44B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.0x

P/E (TTM)

—

RSI (14)

66.0

MomentumView details →

1D Return

+0.00%

YTD Return

+27.08%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−3.0x

EV/Sales

5268.8x

P/S (TTM)

6213.2x

P/B (TTM)

3.5x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−116.20%

ROA (TTM)

−94.58%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+4.92%

FCF YoY

—

Revenue CAGR 3Y

−59.45%

EPS CAGR 3Y

+22.46%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

+27.08%

1Y Return

−11.59%

RSI (14)

66.0

vs 50D SMA

+17.58%

vs 200D SMA

+7.77%

Capital & dividendView details →

Debt/Equity

—

Current Ratio

7.09x

Quick Ratio

7.09x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

1.00M

Net Income (TTM)

−1.29B

Op. CF (TTM)

—

Next earningsNov 6, 2026 →

Latest newsMore news →

BrightPath Biophotonics announced its fiscal Q1 (April-June) results on August 14, reporting an expanded recurring loss of 540 million yen, compared with a 240 million yen loss in the same period last year.38d ago

Similar companies

Chiome Bioscience Inc.4583.T CellSource Co.,Ltd.4880.T Tsubota Laboratory Incorporated4890.T PRISM BioLab Co.,LTD206A.T Solasia Pharma K.K.4597.T Noile-Immune Biotech Inc.4893.T Find similar companies →

Latest newsMore news →

BrightPath Biophotonics announced its fiscal Q1 (April-June) results on August 14, reporting an expanded recurring loss of 540 million yen, compared with a 240 million yen loss in the same period last year.38d ago